Clinical Trials Logo

Clinical Trial Summary

Objectives: To assess arterial oxygen partial pressure (PaO2) at defined time points during the preoxygenation and to compare between high flow heated humidified nasal oxygen versus standard preoxygenation with oxygen insufflation via face mask over at least 5 minutes Methods: This randomized, single-blinded, prospective study was conducted at Asan Medical Center in Seoul, Republic of Korea.

Populations: Patients undergoing head and neck surgery Expected outcomes: The course of PaO2 levels is superior to those of the face mask during the whole preoxygenation procedure and after the intubation.


Clinical Trial Description

Rationale & background information:

Pre-oxygenation before general anesthesia is usually achieved using oxygen delivered via a facemask before induction of anesthesia; this potentially extends the time available for securing the airway before hypoxemia to 6 min. The lungs are commonly ventilated with a bag/facemask technique after induction, and this can be repeated if attempts at intubating the trachea are prolonged. However, facemask ventilation has traditionally been avoided in the circumstance which has the risk of gastric insufflation of gas, leading to increased intragastric pressure and raised risk of pulmonary aspiration of stomach contents. In addition, if difficult ventilation is anticipated, facemask ventilation may not be possible at all, and 6 minutes with hypoxemia may be insufficient for intubation.

An ideal preoxygenation to extend apnea tolerance during anesthesia induction is essential to avoid live threatening airway incidents. The high-flow nasal cannula, the OptiFlow System (Thrive, Fisher & Paykel®, Aukland New Zealand), has the ability to deliver warmed and humidified oxygen through specially designed nasal cannula and enable oxygen to be comfortably delivered at rates of > 70 liter/min. Several study showed that nasal delivery of humidified oxygen to paralyzed and anesthetized patients at these rates maintains oxygenation and achieves acceptable carbon dioxide concentration. The investigators hypothesized that an extended apneic period without facemask ventilation could be particularly beneficial to patients undergoing general anaesthesia.

Study goals and objectives:

To assess arterial oxygen partial pressure (PaO2) at defined time points during the preoxygenation and to compare between high flow heated humidified nasal oxygen versus standard preoxygenation with oxygen insufflation via face mask over at least 5 minutes ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03896906
Study type Interventional
Source Asan Medical Center
Contact
Status Completed
Phase N/A
Start date May 8, 2019
Completion date April 7, 2020

See also
  Status Clinical Trial Phase
Completed NCT02960308 - Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
Terminated NCT02602067 - 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients Phase 1
Completed NCT04277273 - Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris N/A
Completed NCT01621295 - Assessing the Patient Experience in Cancer Care N/A
Active, not recruiting NCT03854838 - IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. Phase 2
Completed NCT04151030 - Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure N/A
Completed NCT03012581 - Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types Phase 2
Active, not recruiting NCT04005521 - Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer N/A
Recruiting NCT05011500 - Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC) N/A
Completed NCT05590650 - A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients Phase 1
Terminated NCT03402737 - SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N N/A
Completed NCT04086849 - Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
Completed NCT00001442 - A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer Phase 1
Recruiting NCT04477759 - Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer Phase 1
Terminated NCT00423150 - Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) Phase 2
Recruiting NCT03757091 - Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery N/A
Recruiting NCT04099290 - Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
Withdrawn NCT04679233 - Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients N/A
Not yet recruiting NCT04267627 - Telemedicine Nurse-Led Intervention for Rural Cancer Survivors N/A
Completed NCT00666926 - Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms Phase 1